Conditioned medium from Bifidobacteria infantis protects against Cronobacter sakazakii-induced intestinal inflammation in newborn mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 306, Issue 9, 2014, Pages

  Weng, Meiqian ^a,b   Ganguli, Kriston ^a,b   Zhu, Weishu ^a,b   Shi, Hai Ning ^a,b   Allan Walker, W ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bifidobacterium infantis; Cronobacter sakazakii; Necrotizing enterocolitis; Neonatal intestinal inflammation; Probioticconditioned media

Indexed keywords

I KAPPA B ALPHA; MUCIN; PROBIOTIC AGENT; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIFIDOBACTERIA INFANTIS; BIFIDOBACTERIUM; BODY WEIGHT; CELL DEATH; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CRONOBACTER SAKAZAKII; CULTURE MEDIUM; DRUG EFFECT; ENTERITIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; ILEUM; IN VIVO STUDY; INTESTINE CELL; INTESTINE VILLUS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; TISSUE INJURY;

BIFIDOBACTERIUM INFANTIS; CRONOBACTER SAKAZAKII; NECROTIZING ENTEROCOLITIS; NEONATAL INTESTINAL INFLAMMATION; PROBIOTIC-CONDITIONED MEDIA;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BIFIDOBACTERIUM; BODY WEIGHT; CELL LINE; CELL PROLIFERATION; CRONOBACTER SAKAZAKII; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE INFECTIONS; ENTEROCOLITIS, NECROTIZING; ENTEROCYTES; HUMANS; I-KAPPA B PROTEINS; ILEITIS; ILEUM; MICE; MICE, INBRED C57BL; MUCINS; PROBIOTICS; TRANSCRIPTION FACTOR RELA;

EID: 84900558820     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00183.2013     Document Type: Article

References (39)

1. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M, Hammerman C. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 147: 192-196, 2005.
2. Braga TD, da Silva GA, de Lira PI, de Carvalho Lima M. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr 93: 81-86, 2011.
3. Butel MJ, Roland N, Hibert A, Popot F, Favre A, Tessedre AC, Bensaada M, Rimbault A, Szylit O. Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria. J Med Microbiol 47: 391-399, 1998.
4. Chon JW, Song KY, Kim SY, Hyeon JY, Seo KH. Isolation and characterization of Cronobacter from desiccated foods in Korea. J Food Sci 77: M354-M358, 2012.
5. Christensen RD, Gordon PV, Besner GE. Can we cut the incidence of necrotizing enterocolitis in half-today? Fetal Pediatr Pathol 29: 185-198, 2010.
6. Claud EC, Lu L, Anton PM, Savidge T, Walker WA, Cherayil BJ. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci USA 101: 7404-7408, 2004.
7. Collier-Hyams LS, Zeng H, Sun J, Tomlinson AD, Bao ZQ, Chen H, Madara JL, Orth K, Neish AS. Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-κB pathway. J Immunol 169: 2846-2850, 2002.
8. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125: 921-930, 2010.
9. Drudy D, Mullane NR, Quinn T, Wall PG, Fanning S. Enterobacter sakazakii: an emerging pathogen in powdered infant formula. Clin Infect Dis 42: 996-1002, 2006.
10. Emami CN, Mittal R, Wang L, Ford HR, Prasadarao NV. Recruitment of dendritic cells is responsible for intestinal epithelial damage in the pathogenesis of necrotizing enterocolitis by Cronobacter sakazakii. J Immunol 186: 7067-7079, 2011.
11. Friedemann M. Epidemiology of invasive neonatal Cronobacter (Enterobacter sakazakii) infections. Eur J Clin Microbiol Infect Dis 28: 1297-1304, 2009.
12. Ganguli K, Meng D, Rautava S, Lu L, Walker WA, Nanthakumar N. Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation. Am J Physiol Gastrointest Liver Physiol 304: G132-G141, 2013.
13. Gephart SM, McGrath JM, Effken JA, Halpern MD. Necrotizing enterocolitis risk: state of the science. Adv Neonatal Care 12: 77-87; quiz 88-79, 2012.
14. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 8: 837-848, 2008.
15. Gothefors L, Blenkharn I. Clostridium butyricum and necrotising enterocolitis. Lancet 1: 52-53, 1978.
16. Howard FM, Flynn DM, Bradley JM, Noone P, Szawatkowski M. Outbreak of necrotising enterocolitis caused by Clostridium butyricum. Lancet 2: 1099-1102, 1977.
17. Iversen C, Waddington M, On SL, Forsythe S. Identification and phylogeny of Enterobacter sakazakii relative to Enterobacter and Citrobacter species. J Clin Microbiol 42: 5368-5370, 2004.
18. Kelsey MC, Vince AJ. Clostridia in neonatal faeces. Lancet 2: 100, 1979.
19. Kilonzo-Nthenge A, Rotich E, Godwin S, Nahashon S, Chen F. Prevalence and antimicrobial resistance of Cronobacter sakazakii isolated from domestic kitchens in middle Tennessee, United States. J Food Prot 75: 1512-1517, 2012.
20. Kleessen B, Bunke H, Tovar K, Noack J, Sawatzki G. Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants. Acta Paediatr 84: 1347-1356, 1995.
21. Lawrence G, Bates J, Gaul A. Pathogenesis of neonatal necrotising enterocolitis. Lancet 1: 137-139, 1982.
22. Lee HA, Hong S, Park H, Kim H, Kim O. Cronobacter sakazakii infection induced fatal clinical sequels including meningitis in neonatal ICR mice. Lab Anim Res 27: 59-62, 2011.
23. Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien RI, Tsao LY, Chen CH, Su BH. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 122: 693-700, 2008.
24. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, Oh W. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115: 1-4, 2005.
25. Lin PW, Nasr TR, Berardinelli AJ, Kumar A, Neish AS. The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut. Pediatr Res 64: 511-516, 2008.
26. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host system. Cell 122: 107-118, 2005.
27. Nadler EP, Dickinson E, Knisely A, Zhang XR, Boyle P, Beer-Stolz D, Watkins SC, Ford HR. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res 92: 71-77, 2000.
28. Nanthakumar N, Meng D, Goldstein AM, Zhu W, Lu K, Uauy R, Llano A, Claud EC. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PloS One 6: E17776, 2011.
29. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289: 1560-1563, 2000.
30. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 364: 255-264, 2011.
31. Pagotto FJ, Nazarowec-White M, Bidawid S, Farber JM. Enterobacter sakazakii: infectivity and enterotoxin production in vitro and in vivo. J Food Prot 66: 370-375, 2003.
32. Pasparakis M. Role of NF-kappaB in epithelial biology. Immunol Rev 246: 346-358, 2012.
33. Preidis GA, Saulnier DM, Blutt SE, Mistretta TA, Riehle KP, Major AM, Venable SF, Finegold MJ, Petrosino JF, Conner ME, Versalovic J. Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J 26: 1960-1969, 2012.
34. Sanderson IR, Ezzell RM, Kedinger M, Erlanger M, Xu ZX, Pringault E, Leon-Robine S, Louvard D, Walker WA. Human fetal enterocytes in vitro: modulation of the phenotype by extracellular matrix. Proc Natl Acad Sci USA 93: 7717-7722, 1996.
35. Simmons BP, Gelfand MS, Haas M, Metts L, Ferguson J. Enterobacter sakazakii infections in neonates associated with intrinsic contamination of a powdered infant formula. Infect Control Hosp Epidemiol 10: 398-401, 1989.
36. Stark PL, Lee A. The bacterial colonization of the large bowel of pre-term low birth weight neonates. J Hyg (Lond) 89: 59-67, 1982.
37. Townsend S, Hurrell E, Forsythe S. Virulence studies of Enterobacter sakazakii isolates associated with a neonatal intensive care unit outbreak. BMC Microbiol 8: 64, 2008.
38. Urmenyi AM, Franklin AW. Neonatal death from pigmented coliform infection. Lancet 1: 313-315, 1961.
39. van Acker J, de Smet F, Muyldermans G, Bougatef A, Naessens A, Lauwers S. Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J Clin Microbiol 39: 293-297, 2001.